share_log
Breakings ·  Sep 12 19:30
Kazia Therapeutics Ltd - Receives Exclusive Worldwide License for Pi3K Inhibitor Combinations
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment